Joinn Laboratories China Co Ltd (6127)

Currency in HKD
23.38
+0.92(+4.10%)
Delayed Data·
6127 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected tomorrow
6127 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.7023.96
52 wk Range
6.3128.70
Key Statistics
Bid/Ask
23.38 / 23.46
Prev. Close
22.46
Open
22.7
Day's Range
22.7-23.96
52 wk Range
6.31-28.7
Volume
3.84M
Average Volume (3m)
9.18M
1-Year Change
224.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6127 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.98
Downside
-23.10%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Joinn Laboratories China Co Ltd Company Profile

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment design, production, breeding and sales of research models, non-human primates, and rodents. The company also offers cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

Compare 6127 to Peers and Sector

Metrics to compare
6127
Peers
Sector
Relationship
P/E Ratio
56.2x43.4x−0.6x
PEG Ratio
0.080.810.00
Price/Book
2.7x4.1x2.6x
Price / LTM Sales
11.0x6.3x3.3x
Upside (Analyst Target)
−30.5%3.2%37.4%
Fair Value Upside
Unlock7.1%4.5%Unlock

Analyst Ratings

2 Buy
3 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 17.98
(-23.10% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.51%
Dividend Yield
0.01%
Industry Median 0.89%
Annualised payout
0.00
Paid annually
5-Years Growth
-19.46%
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.05 / 0.0883
Revenue / Forecast
287.34M / 379.94M
EPS Revisions
Last 90 days

6127 Income Statement

FAQ

What Stock Exchange Does Joinn Laboratories China Co Trade On?

Joinn Laboratories China Co is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Joinn Laboratories China Co?

The stock symbol for Joinn Laboratories China Co is "6127."

What Is the Joinn Laboratories China Co Market Cap?

As of today, Joinn Laboratories China Co market cap is 26.05B.

What Is Joinn Laboratories China Co's Earnings Per Share (TTM)?

The Joinn Laboratories China Co EPS (TTM) is 0.51.

When Is the Next Joinn Laboratories China Co Earnings Date?

Joinn Laboratories China Co will release its next earnings report on 25 Aug 2025.

From a Technical Analysis Perspective, Is 6127 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Joinn Laboratories China Co Stock Split?

Joinn Laboratories China Co has split 3 times.

How Many Employees Does Joinn Laboratories China Co Have?

Joinn Laboratories China Co has 2652 employees.

What is the current trading status of Joinn Laboratories China Co (6127)?

As of 25 Aug 2025, Joinn Laboratories China Co (6127) is trading at a price of 23.38, with a previous close of 22.46. The stock has fluctuated within a day range of 22.70 to 23.96, while its 52-week range spans from 6.31 to 28.70.

What Is Joinn Laboratories China Co (6127) Price Target According to Analysts?

The average 12-month price target for Joinn Laboratories China Co is HKD17.97873501, with a high estimate of HKD31.40239913 and a low estimate of HKD6.96837514. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -23.10% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.